News

PolyMedix has initiated a Phase 1 clinical trial in US, which is designed to further evaluate the safety and pharmacokinetic profile of PMX-30063 in female subjects, who have

Bionovo said that Menerba is an oral botanical drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause. Bionovo president and chief

As president, Walovitch will continue to provide medical leadership for the entire organisation. He will also be responsible for directing the operations, regulatory, sales and marketing activities and

Bailey will replace David Rosenthal, who has served as interim president and CEO since 27 February 2010. Rosenthal said that they were pleased that Bailey has chosen to

China Medicine has posted a net income of $2.22m for the third quarter 2010, or $0.06 per diluted share, compared to a net income of $3.22m, or $0.21

The collaboration combines Bend Research’s advanced drug formulation capabilities and Quotient Clinical’s clinical-trial design service, RapidFACT (Rapid Formulation development And Clinical Testing). RapidFACT represents a new paradigm for

ProPhase Labs has posted a net loss of $947,000 for the third quarter 2010, or $0.06 loss per diluted share, compared to net loss of $1.2m, or $0.09

SuperGen said that the dose limiting toxicity of cardiac QTc prolongation was identified previously in the Phase 1 study in patients with refractory prostate and lymphoma. Additional detailed

Nuvo is primarily focused on the R&D of drug products delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development